Layer 1
Pregabalin

Refine

E.g., 21/09/2019
E.g., 21/09/2019

Refine

Refine

E.g., 21/09/2019
E.g., 21/09/2019

pregabalin

PREMIUM
From this pharmacy CPD module, you will learn about: How medicines misuse is defined and the extent of the problem Which medicines are dependence-...
06/06/2019 0
The misuse of gabapentin and pregabalin has been rapidly rising over the past few years. So, it came as little surprise to me when I heard the...
30/05/2019 2
Leyla Hannbeck: Reclassification of pregabalin and gabapentin could lead to fewer prescriptions
Gabapentin and pregabalin continue to be among the most commonly confused medicines in pharmacies, Leyla Hannbeck's revealed in her latest MSO report...
01/05/2019 9
In October, the Home Office announced that from today (April 1) the drugs – used to treat anxiety, nerve pain and epilepsy – would be placed in...
01/04/2019 9
PREMIUM
From this pharmacy CPD module you will learn about: The causes, risk factors and symptoms of neuropathic pain How the condition is diagnosed and...
14/03/2019 0
NPA: Pharmacists and their teams should ensure prescriber details are authentic
Greater Manchester Police has told the National Pharmacy Association (NPA) that a number of pharmacies in South Manchester – “particularly [in]...
07/03/2019 17
NHS Digital: 64 GP practices can now send schedule 2 and 3 drugs via the EPS
Sixty four GP practices across England can now send schedule 2 and 3 controlled drugs via the electronic prescription service (EPS), following a...
15/02/2019 13
All EMIS practices will issue paper FP10 prescriptions for pregabalin and gabapentin by February 15
The drugs – used to treat anxiety, nerve pain and epilepsy – will be placed in schedule 3 under the Misuse of Drugs Regulations 2001, but will be ...
12/02/2019 13
EXCLUSIVE
The court dismissed Pfizer’s attempt to prevent generic pregabalin from being used to treat certain types of pain, such as neuropathic pain,...
15/11/2018 0
Pfizer argued its branded pregabalin should be the only version prescribed for pain
The legal battle was last seen in the Court of Appeal in 2016, which upheld the previous year’s High Court decision that Pfizer’s patent for...
15/11/2018 2

Pages